Introduction
Glycated haemoglobin(HbA1c) remains the most powerful outcome measure for children and young people with diabetes. It is collected at every clinic visit and is used for individualised discussions around diabetes control and for national benchmarking. However, despite DCCT and IFCC standardisation, there is still no overall consensus as to the most appropriate methodology, particularly when assessing patients with haemoglobinopathies that may affect HbA1c measurement.
Aim
To describe the methods of glycaemic monitoring in paediatric diabetes units (PDU) across England and Wales. • Considerable variation in the methods of glycaemic monitoring in paediatric diabetes patients exists nationally
Methods
• There is lack of awareness among clinician of factors which may impinge on HbA1c results and a significant no of units continue to use it when there are obvious interferences
When are the HbA1c measured ?
• On the day of the appointment = 95%
• Before the appointment = 5% 
When are laboratory HbA1c performed ?
• At all annual reviews n=46/82
• When there is clinical indication n=14/82 • Never n= 22/82 
